Spots Global Cancer Trial Database for CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Official Title: A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Study ID: NCT04145700
Conditions
Study Description
Brief Summary: This study is being conducted to test the safety and efficacy of ramucirumab in combination with other chemotherapy in the treatment of relapsed, recurrent, or refractory synovial sarcoma (SS) in children and young adults. This trial is part of the CAMPFIRE master protocol (NCT05999994) which is a platform to accelerate the development of new treatments for pediatric and young adult participants with cancer. Your participation in this trial could last 12 months or longer, depending on how you and your tumor respond.
Detailed Description:
Eligibility
Minimum Age: 12 Months
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Childrens Hospital of Alabama, Birmingham, Alabama, United States
Phoenix Children's Hospital, Phoenix, Arizona, United States
Childrens Hospital of Los Angeles, Los Angeles, California, United States
UCLA Medical Center, Los Angeles, California, United States
Childrens Hospital of Orange County, Orange, California, United States
Children's Hospital of Colorado, Aurora, Colorado, United States
Children's National Medical Center, Washington, District of Columbia, United States
Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Riley Hospital for Children, Indianapolis, Indiana, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
University of Minnesota Hospital, Minneapolis, Minnesota, United States
Children's Mercy Hospital, Kansas City, Missouri, United States
Washington University Medical School, Saint Louis, Missouri, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Nationwide Children's Hosp, Columbus, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Children's Medical Center Dallas, Dallas, Texas, United States
Cook Children's Hospital, Fort Worth, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Seattle Children's Hospital Research Foundation, Seattle, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
The Sydney Children's Hospitals Network, Westmead, New South Wales, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Royal Children's Hospital, Parkville, Victoria, Australia
Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium
UCL- Saint Luc, Bruxelles, , Belgium
Centre Leon Berard, Lyon, Rhône-Alpes, France
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, , France
Institut Curie, Paris, , France
Universitaetsklinikum Freiburg, Freiburg, Baden-Württemberg, Germany
Universitaetsklinikum Essen, Essen, , Germany
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, , Germany
Istituto Nazionale dei Tumori, Milano, Lombardie, Italy
Istituto Clinico Humanitas, Rozzano, Milano, Italy
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, Italy
Azienda Ospedaliera Di Padova, Padova, , Italy
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Kyushu University Hospital, Fukuoka, , Japan
Leids Universitair Medisch Centrum, Leiden, , Netherlands
Prinses Maxima Centrum, Utrecht, , Netherlands
Hospital Universitario Virgen Del Rocio, Sevilla, Andalucía, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain
Hospital Universitari Vall d'Hebron, Barcelona, , Spain
Hospital Universitario de Canarias, La Laguna, , Spain
Hospital Universitario La Paz, Madrid, , Spain
The Christie, Manchester, Greater Manchester, United Kingdom
University College Hospital - London, London, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
Royal Manchester Children's Hospital, Manchester, , United Kingdom
Contact Details
Name: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Affiliation: Eli Lilly and Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
